IL192263A - Granular material containing water-insoluble organic metal compound, dosing unit, process for making the granular material and the use of the granular material for drug production - Google Patents

Granular material containing water-insoluble organic metal compound, dosing unit, process for making the granular material and the use of the granular material for drug production

Info

Publication number
IL192263A
IL192263A IL192263A IL19226308A IL192263A IL 192263 A IL192263 A IL 192263A IL 192263 A IL192263 A IL 192263A IL 19226308 A IL19226308 A IL 19226308A IL 192263 A IL192263 A IL 192263A
Authority
IL
Israel
Prior art keywords
granular material
medicament
manufacture
preparation
water
Prior art date
Application number
IL192263A
Other languages
English (en)
Hebrew (he)
Other versions
IL192263A0 (en
Original Assignee
Ineos Silicas Ltd
Cytochroma Dev Inc
Ineos Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38006917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL192263(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0601899.8A external-priority patent/GB0601899D0/en
Priority claimed from GB0603984A external-priority patent/GB0603984D0/en
Application filed by Ineos Silicas Ltd, Cytochroma Dev Inc, Ineos Healthcare Ltd filed Critical Ineos Silicas Ltd
Publication of IL192263A0 publication Critical patent/IL192263A0/en
Publication of IL192263A publication Critical patent/IL192263A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)
IL192263A 2006-01-31 2008-06-17 Granular material containing water-insoluble organic metal compound, dosing unit, process for making the granular material and the use of the granular material for drug production IL192263A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0601899.8A GB0601899D0 (en) 2006-01-31 2006-01-31 Compositions
GB0603984A GB0603984D0 (en) 2006-02-28 2006-02-28 Material
PCT/GB2007/000308 WO2007088343A2 (en) 2006-01-31 2007-01-30 Granular material comprising water- insoluble inorganic phosphate binders

Publications (2)

Publication Number Publication Date
IL192263A0 IL192263A0 (en) 2008-12-29
IL192263A true IL192263A (en) 2016-06-30

Family

ID=38006917

Family Applications (1)

Application Number Title Priority Date Filing Date
IL192263A IL192263A (en) 2006-01-31 2008-06-17 Granular material containing water-insoluble organic metal compound, dosing unit, process for making the granular material and the use of the granular material for drug production

Country Status (20)

Country Link
US (2) US9168270B2 (de)
EP (1) EP1993514B1 (de)
JP (2) JP5457681B2 (de)
KR (4) KR101794747B1 (de)
CN (1) CN103751114B (de)
AR (1) AR059266A1 (de)
AU (1) AU2007211375B2 (de)
BR (1) BRPI0706763A2 (de)
CA (2) CA2917335C (de)
CR (2) CR10185A (de)
DK (1) DK1993514T3 (de)
ES (1) ES2564149T3 (de)
IL (1) IL192263A (de)
MX (1) MX343415B (de)
MY (1) MY157620A (de)
NO (1) NO342570B1 (de)
NZ (1) NZ569408A (de)
RU (1) RU2437650C2 (de)
TW (1) TWI328459B (de)
WO (1) WO2007088343A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
GB0502787D0 (en) * 2005-02-10 2005-03-16 Ineos Silicas Ltd Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
EP2918548A1 (de) 2006-12-14 2015-09-16 Novartis Tiergesundheit AG Auf eisen(iii)-zucker basierendes phosphat-adsorbens
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
PE20120327A1 (es) * 2009-03-02 2012-04-11 Vifor Int Ag Composicion adsorbente de fosfato a base de calcio, magnesio y hierro
AU2014218455B2 (en) * 2009-07-21 2016-11-24 Keryx Biopharmaceuticals, Inc. Ferric Citrate Dosage Forms
MX2012000892A (es) 2009-07-21 2012-06-01 Keryx Biopharmaceuticals Inc Formas de dosificacion de citrato ferrico.
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
KR20130048725A (ko) * 2010-03-15 2013-05-10 다이쇼 세이야꾸 가부시끼가이샤 안료 조성물
TWI556823B (zh) * 2010-04-27 2016-11-11 拜耳智慧財產有限公司 含阿卡波糖之口崩解錠
TWI382842B (zh) * 2010-09-23 2013-01-21 Univ Nat Chunghsing 快速製備磷結合劑的方法及含磷結合劑的醫藥組合物
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
CA2880163A1 (en) * 2012-08-01 2014-02-06 Acura Pharmaceuticals, Inc. Stabilization of one-pot methamphetamine synthesis systems
GB201217911D0 (en) * 2012-10-05 2012-11-21 Oxford Pharmascience Ltd Layered double hydroxides
US10272057B2 (en) 2012-10-05 2019-04-30 Oxford Pharmascience Limited Layered double hydroxides
EP3073997B1 (de) * 2013-11-27 2020-06-03 Vifor (International) AG Pharmazeutische zusammensetzung mit phosphatbindemittelteilchen
WO2015193087A1 (en) * 2014-06-18 2015-12-23 Unilever N.V. Layered double hydroxides for purification of water
JP5757493B1 (ja) * 2014-09-24 2015-07-29 富田製薬株式会社 経口型鉄分補給用固形組成物及びその製造方法
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
KR102001144B1 (ko) * 2016-03-04 2019-07-17 주식회사 엘지화학 페라이트계 촉매 복합체, 제조방법 및 부타디엔의 제조방법
US11278439B2 (en) 2016-03-07 2022-03-22 Orthotic Care Services, LLP Ankle-foot orthosis
US10392267B2 (en) * 2017-04-18 2019-08-27 King Abdulaziz University Azo dye intercalated Fe(II)/Fe(III) layered double hydroxide for water purification
JP2019182818A (ja) * 2018-04-17 2019-10-24 ライオン株式会社 舌苔除去用の口腔内崩壊錠及び舌苔除去方法
EA202191134A1 (ru) 2018-10-25 2021-07-13 Эйрджен Фарма Лтд. Способы лечения смешанными металлосодержащими соединениями
JP2023545511A (ja) * 2020-10-17 2023-10-30 デイビッド アンダーソン オリベトール酸誘導体の製剤および非共有結合性安定化

Family Cites Families (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1304104A (en) * 1919-05-20 Dough-treating device
US1214473A (en) * 1916-05-22 1917-01-30 John Henry Jenner Adjustable wrench.
US1336866A (en) * 1917-07-23 1920-04-13 John H Schlueter Vessel
US1413197A (en) * 1919-02-10 1922-04-18 John C Swan Apparatus for excluding water from drilled wells for oil
US2061136A (en) * 1931-07-25 1936-11-17 Winthrop Chem Co Inc Process of preparing racemic compounds of the 1-hydroxyphenyl-2-aminopropan-1-ol series
US2222924A (en) 1936-12-10 1940-11-26 Degussa Preparation of cerium sulphate
US2254556A (en) * 1940-04-26 1941-09-02 Jay E Wagner Anatomical dental flask
US2812344A (en) 1956-02-13 1957-11-05 Ortho Pharma Corp Ferrous calcium citrate complex
FR1214473A (fr) 1959-01-07 1960-04-08 Procédé de préparation d'un catalyseur à base d'hydroxyde de cérium
US3001114A (en) * 1959-04-16 1961-09-19 Lee N Hermann Transistor controlled electronic clock
BE590192A (de) 1959-04-27
US3402878A (en) * 1965-05-28 1968-09-24 Andersson Carl Harry Lennart Tray combined with a breadbox
US3395211A (en) 1965-12-10 1968-07-30 Carter Wallace Tableting process
US3539306A (en) 1966-07-25 1970-11-10 Kyowa Chem Ind Co Ltd Process for the preparation of hydrotalcite
AT309837B (de) * 1968-02-27 1973-09-10 Elin Union Ag Verfahren zur Aushärtung von Legierungen
US3879523A (en) 1969-12-12 1975-04-22 Kyowa Chem Ind Co Ltd Composite metal hydroxides
SU414849A1 (ru) 1971-05-21 1977-09-05 Харьковский домостроительный комбинат Бетонна смесь
BE792032A (fr) 1971-12-23 1973-03-16 Baxter Laboratories Inc Dispositif de transfert de masse ayant une membrame semi-permeable disposee en spirale et presentant un faible volume de fluide
NL174720C (nl) 1973-12-13 1984-08-01 Philips Nv Beeldweergeefcel en methode voor de vervaardiging van een vloeibaar kristallijn p-n.butyl-p'-alkoxyazobenzeen.
PL110490B1 (en) 1976-05-19 1980-07-31 Politechnika Poznanska Agent for preparing hydrophobic solutions extracting ions of non ferrous metals from aqueous solutions also a method of producing an agent for preparing hydrophobic solutions extracting ions of non ferrous metals
DE2642984C3 (de) 1976-09-24 1980-01-24 Maschinenfabrik Karl Brieden & Co, 4630 Bochum Blasversatzleitung mit stirnseitigem Austrag
FR2435442A1 (fr) 1978-09-07 1980-04-04 Om Lab Sa Silicate de magnesium et d'aluminium synthetique, procede de fabrication de celui-ci et compositions pharmaceutiques comprenant celui-ci
US4192900A (en) 1978-10-12 1980-03-11 Merck & Co., Inc. Texturized starch products
DE2845326C2 (de) 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE3039997A1 (de) 1980-10-23 1982-06-03 Bayer Ag, 5090 Leverkusen Phosphonohydroxyacetonitril, ein verfahren zu seiner herstellung und seine verwendung als zwischenprodukt fuer die herstellung von arzneimitteln
US4351814A (en) 1980-12-18 1982-09-28 Kyowa Chemical Industry Co., Ltd. Hydrotalcites having a hexagonal needle-like crystal structure and process for production thereof
JPS57156419A (en) * 1981-03-24 1982-09-27 Kyowa Chem Ind Co Ltd Remedy for sideropenia
US4514389A (en) 1981-05-06 1985-04-30 Kyowa Chemical Industry Co. Ltd. Gastric antacid and method for controlling pH of gastric juice
CA1198674A (en) 1981-11-23 1985-12-31 Rorer International (Holdings) Inc. Antacid compositions
US4458026A (en) 1982-06-02 1984-07-03 Union Carbide Corporation Catalysts for aldol condensations
US4582705A (en) 1982-07-12 1986-04-15 Leonard Primes Composition for detoxification
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
GB8317595D0 (en) 1983-06-29 1983-08-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4609543A (en) 1983-11-14 1986-09-02 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS60131604A (ja) 1983-12-20 1985-07-13 Victor Co Of Japan Ltd 磁気記録再生素子
DE3346943A1 (de) 1983-12-24 1985-07-04 Bayer Ag, 5090 Leverkusen Herstellung von hydrotalcit mit verbesserten eigenschaften
DE3402878A1 (de) 1984-01-27 1985-08-01 Algina AG, Zug Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel
FR2559755A1 (fr) 1984-02-20 1985-08-23 Rhone Poulenc Spec Chim Oxyde cerique a nouvelles caracteristiques morphologiques et son procede d'obtention
JPS6136222A (ja) 1984-07-26 1986-02-20 Chugai Pharmaceut Co Ltd 高リン酸血症治療剤
US4566986A (en) 1984-08-31 1986-01-28 Waldmann John J Flocculating agents and processes for making them
DE3520108A1 (de) 1985-06-05 1986-12-11 Varta Batterie Ag, 3000 Hannover Positive sammlerelektrode fuer akkumulatoren mit alkalischem elektrolyten
JPH06705B2 (ja) 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US4871392A (en) 1986-05-23 1989-10-03 American Cyanamid Company Aqueous suspension concentrate compositions of pendimethalin
US4801454A (en) 1986-07-17 1989-01-31 The Proctor & Gamble Company Processes for making colored pharmaceutical compositions
EP0300853B1 (de) 1987-06-29 1991-09-18 Rhone-Poulenc Chimie Verfahren zur Gewinnung eines Ceriumoxids
US4786510A (en) 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
US4994283A (en) 1987-07-02 1991-02-19 The Procter & Gamble Company Iron-calcium mineral supplements with enhanced bioavailability
DE3801382A1 (de) 1988-01-19 1989-08-03 Ebner Anlagen & Apparate Verfahren und anlage zur umwandlung von natriumsulfat in natriumhydroxid
DE68916983T2 (de) 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
HU201880B (en) 1988-06-21 1991-01-28 Semmelweis Orvostudomanyi Egye Process for producing pharmaceutical compositions for profilacting and treating renal diseases and for diminishing frequency of extracorporalis dialysis
GB8826333D0 (en) 1988-11-10 1988-12-14 Unilever Plc Oral compositions
GB8902581D0 (en) 1989-02-06 1989-03-22 Telephone Cables Ltd Optical fibre cable core
US5153156A (en) 1989-04-18 1992-10-06 Aristech Chemical Corporation Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone
FR2647433B1 (fr) 1989-05-23 1991-10-31 Lafarge Coppee Da Procede de preparation par voie aqueuse de sulfate de calcium purifie
US4970079A (en) 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
US5208816A (en) * 1989-08-18 1993-05-04 At&T Bell Laboratories Generalized viterbi decoding algorithms
US5112604A (en) 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
ES2018952A6 (es) 1989-10-17 1991-05-16 Walton Sa Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
JP2918619B2 (ja) 1990-04-06 1999-07-12 花王株式会社 金属磁性粉末の製造方法及び磁気記録媒体用塗膜
CA2082639A1 (en) * 1990-06-08 1991-12-09 Terence William Turney Ethylene sorbing substances
US5300302A (en) 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
DE4036757A1 (de) 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
GB2253164B (en) 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
GB2254556B (en) 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid
US5246899A (en) 1991-08-16 1993-09-21 Amoco Corporation Simplified preparation of hydrotalcite-type clays
JPH05155776A (ja) 1991-12-02 1993-06-22 Otsuka Pharmaceut Factory Inc 高リン血症治療剤
JPH05208816A (ja) 1992-01-28 1993-08-20 Sumitomo Metal Mining Co Ltd 水酸化セリウム及び酸化セリウムの製造方法
WO1993022237A1 (en) 1992-04-30 1993-11-11 J.M. Huber Corporation Method for production of synthetic hydrotalcite
US5380542A (en) 1992-06-19 1995-01-10 Rhone-Poulenc Specialties Chemical Co. Dietary fiber compositions for use in foods
US5273767A (en) 1992-09-09 1993-12-28 Merck & Co., Inc. Rapidly hydrating gums
WO1994009798A1 (en) 1992-10-29 1994-05-11 C-P Technology Limited Partnership Mixtures or complexes containing calcium and sulfate
NL9201907A (nl) 1992-11-02 1994-06-01 Tno Peristaltisch mengende reactor en peristaltische kleppenpomp.
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
CA2110313C (en) 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
TW397686B (en) 1993-08-11 2000-07-11 Takeda Chemical Industries Ltd Antacid compositions and pharmaceutical compositions
WO1995011033A1 (en) 1993-10-22 1995-04-27 Commonwealth Scientific And Industrial Research Organisation Polyoxometallates in the treatment of flavivirus infections
TW390813B (en) 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
WO1996009034A1 (en) 1994-09-21 1996-03-28 Unilever N.V. Oral compositions
GB9506126D0 (en) 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
AU727323B2 (en) 1995-09-20 2000-12-07 University Of Queensland, The Novel ACC synthase genes
US5571336A (en) 1995-09-29 1996-11-05 Wurzburger; Stephen R. Base solution for cleaning aluminum
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
IL125422A (en) 1996-01-25 2001-03-19 Colon Leslie Young Stomach-action molluscicides comprising hydroxy-metal or non hydroxy-metal complexone
SE9602442D0 (sv) 1996-06-20 1996-06-20 Astra Ab Administration of pharmaceuticals
AU713462B2 (en) 1996-07-12 1999-12-02 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
US6180094B1 (en) * 1996-07-19 2001-01-30 Nikken Chemicals Co., Ltd. Remedies for hyperphosphatemia
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
JPH1059842A (ja) 1996-08-13 1998-03-03 Lion Corp 錠剤用組成物及び打錠方法
JPH10101569A (ja) 1996-10-01 1998-04-21 Eisai Co Ltd 制酸剤
JPH10236960A (ja) 1997-02-24 1998-09-08 Lion Corp 制酸剤含有組成物
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6028023A (en) 1997-10-20 2000-02-22 Bulldog Technologies U.S.A., Inc. Process for making, and use of, anionic clay materials
BR9908438A (pt) 1998-03-06 2000-10-31 Eurand Int Tabletes de desintegração rápida
JPH11335269A (ja) 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
DE19958007A1 (de) * 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
WO2001049025A1 (en) * 1999-12-24 2001-07-05 Fujitsu Limited Information recording/reproducing device
JP2003519189A (ja) 2000-01-06 2003-06-17 マランテック ホールディング リミテッド ライアビリティ カンパニー 多価電子活性組成物、その製造方法及び使用方法
US6672918B2 (en) * 2000-01-17 2004-01-06 Yamaha Marine Kabushiki Kaisha Induction system for 4-cycle engine of small watercraft
AUPQ533700A0 (en) 2000-01-28 2000-02-17 Commonwealth Scientific And Industrial Research Organisation Soil treatment method
JP4439067B2 (ja) 2000-02-23 2010-03-24 三菱原子燃料株式会社 鉄系複水酸化物の製造方法及び該複水酸化物を用いた水処理材
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
JP2002011243A (ja) * 2000-04-27 2002-01-15 Sony Computer Entertainment Inc 記録媒体、プログラム、エンタテインメントシステムおよびエンタテインメント装置
WO2001087042A2 (en) * 2000-05-15 2001-11-22 James Martindale Tine system
FR2809407B1 (fr) 2000-05-26 2002-08-30 Rhodia Chimie Sa Utilisation d'hydrotalcite comme charge dans des compositions de polymeres
US20030185886A1 (en) 2000-05-26 2003-10-02 Hanmi Pharm. Co., Ltd. Process for the preparation of rapidly disintegrating tablet
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
AU2002224357A1 (en) * 2000-10-11 2002-04-22 Zymogenetics Inc. Mammalian wnt polypeptide-5
US6576665B2 (en) 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
JP4061857B2 (ja) * 2001-04-27 2008-03-19 株式会社日立製作所 光学ユニット及びそれを用いた映像表示装置
US20040247696A1 (en) 2001-07-05 2004-12-09 Antelman Marvin S. Methods of using electron active compounds for managing conditions afflicting mammals
UA80682C2 (en) 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
US7147868B2 (en) 2001-08-27 2006-12-12 Kyowa Chemical Industry Co., Ltd. Antacid and laxative tablets
AR036354A1 (es) 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
EP1430888A1 (de) 2001-09-28 2004-06-23 Sanwa Kagaku Kenkyusho Co., Ltd. Druckbeschichtete sich schnell zersetzende geformte gegenstände
GB0204771D0 (en) 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
SK50232004A3 (sk) 2002-04-29 2005-04-01 Egis Gy�Gyszergy�R Rt. Spôsob prípravy tabliet z farmaceuticky aktívnych látok, ktoré majú nevýhodné tabletačné vlastnosti s granulačnou kvapalinou obsahujúcou mikrokryštalickú celulózu
US20040161474A1 (en) 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
CN1970680B (zh) 2002-06-25 2015-08-26 罗狄亚公司 油井压裂剂
US6729847B2 (en) * 2002-07-29 2004-05-04 Attwood Corporation Bilge pump seal and float actuator
ATE350157T1 (de) 2002-08-09 2007-01-15 Albemarle Netherlands Bv Fischer-tropsch-verfahren unter verwendung eines eisenhaltigen schichtförmigen materiales
JP4348426B2 (ja) 2002-08-29 2009-10-21 独立行政法人産業技術総合研究所 高選択性脱リン剤及びその製造方法
TW563685U (en) * 2002-10-03 2003-11-21 Well Shin Entpr Co Ltd Structure for wire reeling device
ES2389919T3 (es) 2002-10-04 2012-11-05 Tyco Healthcare Group Lp Disector de balón con cánula
US7625492B2 (en) 2003-01-28 2009-12-01 The University Of Wyoming Research Corporation Charge-based water filtration systems
US6866519B2 (en) * 2003-07-10 2005-03-15 Wei-Fang Fan Adaptable resilient pin assembly for BGA based IC encapsulation
US7283517B2 (en) * 2003-07-22 2007-10-16 Innomedia Pte Stand alone multi-media terminal adapter with network address translation and port partitioning
AR045068A1 (es) 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
US20050027876A1 (en) * 2003-07-29 2005-02-03 Toshitomo Umei Data transmission method, data transmission system, and data transmission apparatus
SI2172205T1 (sl) 2003-08-26 2014-10-30 Shire Biopharmaceuticals Holdings Ireland Limited Farmacevtska formulacija obsegajoča lantanove spojine
US7381428B2 (en) 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
WO2005027876A1 (en) 2003-08-28 2005-03-31 Ranbaxy Laboratories Limited Pharmaceutical compositions of benzimidazole and processes for their preparation
BE1015841A3 (fr) 2003-12-24 2005-10-04 Lhoist Rech & Dev Sa Composition pulverulente a base d'un compose calco-magnesien.
US20050170014A1 (en) * 2004-01-30 2005-08-04 Anandi Krishnan Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia
US20050260271A1 (en) 2004-05-20 2005-11-24 Eastman Kodak Company Composition comprising layered host material with intercalated functional-active organic compound
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7361194B2 (en) * 2004-10-14 2008-04-22 Wright Medical Technology, Inc. Metallic bearings for joint replacement
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US20090108233A1 (en) 2004-12-24 2009-04-30 The Univeristy Of Queensland Preparation of suspensions
GB0502787D0 (en) 2005-02-10 2005-03-16 Ineos Silicas Ltd Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
JP4823547B2 (ja) 2005-03-28 2011-11-24 株式会社ジーシー ペースト状歯科用アルギン酸塩印象材組成物
ZA200805646B (en) 2005-12-28 2009-12-30 Takeda Pharmaceutical Controlled release solid preparation
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
JP4899182B2 (ja) 2006-03-22 2012-03-21 独立行政法人産業技術総合研究所 アニオン交換体の製造方法
PL2034958T3 (pl) 2006-05-19 2010-04-30 Norbrook Lab Ltd Stabilna, wodna zawiesina o przyjemnym smaku
EP2918548A1 (de) 2006-12-14 2015-09-16 Novartis Tiergesundheit AG Auf eisen(iii)-zucker basierendes phosphat-adsorbens
SI2319804T1 (sl) 2006-12-14 2015-01-30 Novartis Ag Fosfatni adsorbent na osnovi Ĺľelezo(III)-ogljikovega hidrata
EP1946750A1 (de) 2007-01-18 2008-07-23 The Jordanian Pharmaceutical Manufacturing Co. Kopräzipitat, Herstellungsverfahren und Anwendungen davon
WO2008129034A1 (en) 2007-04-20 2008-10-30 Euro Support Catalyst Group Bv Hydrotalcite-like layered double hydroxide (ldh) composition and process of making same
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
DE102007059990A1 (de) 2007-12-13 2009-06-18 Süd-Chemie AG Verfahren zur Herstellung nanokristalliner Hydrotalcitverbindungen
JP5208816B2 (ja) 2009-03-06 2013-06-12 日本板硝子株式会社 端子付ガラス及び端子付ガラス搭載車両
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Also Published As

Publication number Publication date
CN103751114A (zh) 2014-04-30
AU2007211375A1 (en) 2007-08-09
KR101794747B1 (ko) 2017-11-07
AR059266A1 (es) 2008-03-19
US9168270B2 (en) 2015-10-27
WO2007088343A3 (en) 2008-01-24
US20150132407A1 (en) 2015-05-14
JP2014031381A (ja) 2014-02-20
MY157620A (en) 2016-06-30
KR20170124649A (ko) 2017-11-10
US20090317459A1 (en) 2009-12-24
CR10185A (es) 2008-10-29
KR20160042176A (ko) 2016-04-18
WO2007088343A8 (en) 2007-10-04
KR101731940B1 (ko) 2017-05-02
RU2437650C2 (ru) 2011-12-27
US9907816B2 (en) 2018-03-06
CA2917335A1 (en) 2007-08-09
RU2008135130A (ru) 2010-03-10
KR20140069193A (ko) 2014-06-09
TWI328459B (en) 2010-08-11
JP2009525316A (ja) 2009-07-09
CR20150031A (es) 2015-02-26
AU2007211375B2 (en) 2013-08-29
CA2917335C (en) 2019-07-23
CA2633762A1 (en) 2007-08-09
MX343415B (es) 2016-11-04
KR20080075535A (ko) 2008-08-18
TW200744671A (en) 2007-12-16
KR101509044B1 (ko) 2015-04-06
NO20083682L (no) 2008-10-27
EP1993514B1 (de) 2015-12-09
JP5457681B2 (ja) 2014-04-02
KR101934498B1 (ko) 2019-01-02
NZ569408A (en) 2011-03-31
CA2633762C (en) 2017-11-07
ES2564149T3 (es) 2016-03-18
DK1993514T3 (en) 2016-03-14
EP1993514A2 (de) 2008-11-26
IL192263A0 (en) 2008-12-29
CN103751114B (zh) 2019-07-09
WO2007088343A2 (en) 2007-08-09
BRPI0706763A2 (pt) 2011-04-05
NO342570B1 (no) 2018-06-18

Similar Documents

Publication Publication Date Title
IL192263A (en) Granular material containing water-insoluble organic metal compound, dosing unit, process for making the granular material and the use of the granular material for drug production
IL275890A (en) A pharmaceutical preparation containing rasgelin and pramipexole
IL234166B (en) Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL193678A (en) Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
IL186303A (en) 1h - benzamideimzole - 4 carboxyamides converted with quarterly carbon in position 2, the pharmaceutical composition containing it and its use for the preparation of a drug @ for the treatment @ of cancer
ZA200704957B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL194835A (en) History of cyclohexylpyrazole-lactam, an intermediate substance for their use in the preparation of drugs
EP1940361A4 (de) Pharmazeutische dosierformen mit sofortiger freisetzung und/oder kontrollierter freisetzung
IL193762A (en) The effective compounds in inhibiting dgat1-related disorders, their medicinal products and their use in the preparation of drugs
PL1928231T3 (pl) Granulowane kompozycje agrochemiczne do kontrolowanego uwalniania i sposób ich wytwarzania
IL202379A (en) Benzoxaborols, their pharmaceutical preparations and their use in the preparation of bacteria to inhibit the growth of germs
IL204887A (en) Acetamide History, Pharmaceuticals Containing Them, Methods of Preparing and Using It in the Preparation of Diabetes Medications
IL196007A0 (en) Pyrazolopyrimidines, a process for their preparation and their use as medicine
IL194699A (en) Tetrahydropridridines, preparations containing them and uses in the preparation of drugs
IL179777A (en) Dosage Forms Dosage Forms Dissipating Fast Dissolving Solid Form Dissolving Containing This Preparation
IL190770A0 (en) Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
IL194678A (en) Kinase inhibitors, pharmaceutical preparations containing them and their uses in the preparation of a drug for the treatment of cancer in mammals
EP2073876A4 (de) Ventile und spender für abgemessene dosen
IL203936A (en) HISTORY 4 - Pyrimidinsulfamide, Process for Preparation, Pharmaceutical Preparations Containing and Using it for Medication Preparation
EP1982590A4 (de) Pestizidhaltige harzzusammensetzungen mit kontrollierter auflösung, verfahren zu ihrer herstellung und pestizidpräparate
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL197871A0 (en) Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers
IL198845A (en) An extended-release peptide preparation, a process for its preparation and use for drug preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees